Randomized, Open Label, Phase III Trial of Figitumumab in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer (NSCLC)
Refereed conference paper presented and published in conference proceedings


Full Text

Other information
All Author(s) ListMOK Shu Kam Tony, JASSEM J., LANGER J. C., KARP D. D., BENNER J. R., GREEN J. S., PARK K., NOVELLO S., STRAUSZ J., GUALBERTO A.
Name of ConferenceASCO Annual Meeting 2010
Country/Region of ConferenceUnited States of America
Proceedings TitleASCO Annual Meeting 2010
Detailed descriptionorganized by American Society of Clinical Oncology,
Year2010
Month6
Place of PublicationUnited States of America
Pages7500
LanguagesEnglish-United Kingdom
KeywordsFigitumumab; Paclitaxel/carboplatin; NSCLC

Last updated on 2018-19-01 at 16:39